glutathione mutations in sclc patients Immunotherapy small-cell lung cancer: from molecular promises to clinical challenges In vivo functional screens reveal
In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Oncology Letters Role of Glutathione in Cancer: From Mechanisms to Therapies Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review Journal of Clinical Oncology Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





